Position in VRTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$10,405,003
+$2,413,724 QoQ
Shares Held
20,947
+17.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#361
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ethic Inc. holds $40,271,041 across 35 Biotechnology names. VRTX ranks #1 (25.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
20,947 | $10,405,003 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,069 | $10,019,664 | |
| 3 | ARGX |
Argenx SE
|
4,376 | $4,059,921 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
31,679 | $2,511,827 | |
| 5 | CYTK |
Cytokinetics Inc
|
18,965 | $1,615,628 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,172 | $1,556,927 | |
| 7 | MRNA |
Moderna, Inc.
|
15,694 | $1,099,050 | |
| 8 | INBX |
Inhibrx Biosciences, Inc.
|
9,345 | $885,438 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,405,003 | 20,947 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $7,991,279 | 17,896 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $7,246,052 | 15,983 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $5,471,602 | 13,971 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $5,117,574 | 11,495 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $5,544,886 | 11,437 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $9,258,073 | 22,990 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,205,328 | 19,793 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,919,052 | 21,162 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,273,671 | 19,793 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,175,912 | 17,636 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,739,448 | 16,505 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,185,745 | 14,736 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,194,841 | 13,314 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,513,252 | 8,703 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,122,617 | 7,331 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,692,148 | 6,005 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $613,018 | 2,349 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $481,363 | 2,192 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $741,159 | 4,086 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $848,862 | 4,210 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $743,734 | 3,461 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $589,668 | 2,495 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $707,239 | 2,599 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $687,454 | 2,368 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $225,576 | 948 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||